// App-Quantinova.ai

1875 : Parallel Transcriptional Analysis of Multiple Stem and Progenitor Populations Identifies Novel Commonly Dysregulated and Functionally Relevant Targets in AML

Researchers

Presenter

  • Britta Will

Principal Investigators

  • Elisabeth Paietta

  • Rhett P Ketterling

  • Larry D Cripe

  • Hugo F Fernandez

  • Peter L. Greenberg

  • Jacob M Rowe

  • Martin S. Tallman

  • Christian Steidl

  • Constantine S. Mitsiades

  • Amit Verma

  • Li Zhou

  • Ulrich Steidl

  • Tihomira I Todorova

  • Robert Stanley

  • Susana Ben-Neriah

  • Cristina Montagna

  • Samir Parekh

  • Andrea Pellagatti

  • Jacqueline Boultwood

Medical Centers

  • Department of Neurology, Albert Einstein College of Medicine, Bronx, NY

  • Shaare Zedek Medical Center, Jerusalem, Israel

  • LRF Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, Oxford, United Kingdom

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Locations

  • United States

  • Canada

  • United Kingdom

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Cluster of Differentiation 34

  • Cluster of Differentiation 38

  • Protein Tyrosine Phosphatase, Receptor Type C

  • Fms related tyrosine kinase 3

  • Glomeruloid microvascular proliferation

  • Interleukin 1

  • Thy-1 Cell Surface Antigen

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved